Proline-rich polypeptide from ovine colostrum: its effect on skin permeability and on the immune response. 1979

Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski

The effect of a proline-rich polypeptide from ovine colostrum on the humoral immune response in mice against sheep red blood cells (SRBC) was studied. It was shown that the polypeptide had a regulatory activity stimulating or suppressing the immune response. The proline-rich polypeptide also increased the permeability of skin vessels in guinea-pigs. Studies on the mechanism of the effect of the proline-rich polypeptide suggest that prostaglandins are involved in the activity of the polypeptide.

UI MeSH Term Description Entries
D008297 Male Males
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D011448 Prostaglandin Antagonists Compounds that inhibit the action of prostaglandins. Prostaglandin Inhibitors,Antagonists, Prostaglandin,Inhibitors, Prostaglandin,Prostaglandin Antagonist,Prostaglandin Inhibitor,Antagonist, Prostaglandin,Inhibitor, Prostaglandin
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D003126 Colostrum The thin, yellow, serous fluid secreted by the mammary glands during pregnancy and immediately postpartum before lactation begins. It consists of immunologically active substances, white blood cells, water, protein, fat, and carbohydrates. Colostrums
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005260 Female Females
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea

Related Publications

Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
January 1988, Postepy higieny i medycyny doswiadczalnej,
Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
January 1993, Archivum immunologiae et therapiae experimentalis,
Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
December 1974, FEBS letters,
Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
January 2008, Advances in experimental medicine and biology,
Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
October 2002, Medical science monitor : international medical journal of experimental and clinical research,
Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
January 1998, Archivum immunologiae et therapiae experimentalis,
Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
January 2001, European cytokine network,
Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
October 1987, Molecular immunology,
Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
January 1996, Archivum immunologiae et therapiae experimentalis,
Z Wieczorek, and M Zimecki, and M Janusz, and K Staroscik, and J Lisowski
July 2007, International immunopharmacology,
Copied contents to your clipboard!